Brain Scan Articles & Analysis
12 news found
In the future, we hope this type of biomarker response will help predict a therapeutic benefit long before clinical benefits can be measured.” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) ...
Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, adds the potential for more precise and objective brain scan analysis. Qynapse’s predictive AI technology, QyPredict®, available for research-use-only, has the potential to predict disease trajectory and improve targeted patient selection in clinical trials. ...
ByQynapse
The posters highlight Qynapse’s latest results with QyScore®, its commercially-available automated brain image analysis platform, demonstrating the reproducibility of its results and its value to inform the MS diagnostic standard. ...
ByQynapse
Qynapse will demo its flagship FDA-cleared and CE-marked neuroimaging solution, QyScore®, which combines MRI scans and AI to produce rapid, actionable insights into CNS disorders, such as Alzheimer’s disease, multiple sclerosis and Parkinson’s disease. ...
ByQynapse
Qynapse’s flagship solution, QyScore®, FDA-Cleared and CE-Marked, combines MRI scans and artificial intelligence to produce rapid, actionable insights into CNS disorders, adding the potential for more precise and objective brain scan analysis. ...
ByQynapse
It provides a quick, non-invasive and objective aid to diagnosis, providing a low-cost alternative to brain scans. The improved accuracy over other solutions provides advantages – in particular for measuring response to dopaminergic medication. ...
However, regular MRI images are of limited use in the differential diagnosis of dementia or estimating its severity as they don’t show enough detail. Brain MRI scans are currently used to rule out other neurodegenerative diseases rather than directly diagnose the cause of dementia and do not help in early diagnosis. ...
Ongoing or repeat bleeding in the brain contributes to decreased brain function and disability and may be difficult to detect under the current standard of care. There is currently no objective way to detect brain injury and stroke subtype in a field environment, or to continuously monitor brain injury for expanded hemorrhage in ...
Neurosurgery procedures are extremely complex requiring high precision to avoid damage to vital structures of the brain. Neuronavigation systems help to guide surgeons to perform an even more accurate surgery, decreasing the percentage of serious damage to these vital structures. ...
ByAxial3D
Dr Steven Chance, CEO, Oxford Brain Diagnostics said ‘we are very excited to be working with our partners and the NIHR on this project. ...
CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate assessment of the neurodegeneration associated with Alzheimer’s disease and other dementias. ...
“Data is the fuel for AI, and Evoke has generated a cross-sectional database of over 58,000 computational EEG brain scans. This means Evoke has an exceptional vantage point to develop insights into EEG data interpretation that can be useful in novel diagnostic approaches,” said Neil Sahota. “I’m excited to be a part of Evoke Neuroscience ...